Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery

NCT02511821 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2021-01-07

No results posted yet for this study

Summary

This pilot clinical trial studies an electronic monitoring device of patient-reported outcomes (PROs) and function in improving patient-centered care in patients with gastrointestinal cancer undergoing surgery. Electronic monitoring is a technology-based way of asking patients about the quality of life, symptoms, and activity using online surveys and an activity tracking watch may make it easier for patients to tell their doctors and nurses about any issues before and after surgery. Electronic systems of assessing PROs may increase the depth and accuracy of available clinical data, save administrative time, prompt early intervention that improves the patient experience, foster patient-provider communication, improve patient safety, and enhance the consistency of data collection across multiple sites.

Conditions

  • Stage I Adult Liver Cancer
  • Stage I Colorectal Cancer
  • Stage IA Gastric Cancer
  • Stage IA Pancreatic Cancer
  • Stage IB Gastric Cancer
  • Stage IB Pancreatic Cancer
  • Stage II Adult Liver Cancer
  • Stage IIA Colorectal Cancer
  • Stage IIA Gastric Cancer
  • Stage IIA Pancreatic Cancer
  • Stage IIB Colorectal Cancer
  • Stage IIB Gastric Cancer
  • Stage IIB Pancreatic Cancer
  • Stage IIC Colorectal Cancer
  • Stage III Pancreatic Cancer
  • Stage IIIA Adult Liver Cancer
  • Stage IIIA Colorectal Cancer
  • Stage IIIA Gastric Cancer
  • Stage IIIB Adult Liver Cancer
  • Stage IIIB Colorectal Cancer
  • Stage IIIB Gastric Cancer
  • Stage IIIC Adult Liver Cancer
  • Stage IIIC Colorectal Cancer
  • Stage IIIC Gastric Cancer
  • Stage IV Gastric Cancer
  • Stage IVA Colorectal Cancer
  • Stage IVA Liver Cancer
  • Stage IVA Pancreatic Cancer
  • Stage IVB Colorectal Cancer
  • Stage IVB Liver Cancer
  • Stage IVB Pancreatic Cancer

Interventions

OTHER

Computer-Assisted Intervention

Complete online surveys

DEVICE

Vivofit watch

Wear Vivofit watch

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • City of Hope Medical Center

    lead OTHER

Principal Investigators

  • Virginia Sun · City of Hope Medical Center

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-22
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02511821 on ClinicalTrials.gov